Impairment of the inhibitory effect of sodium on basophil histamine release in patients with systemic sclerosis

Abstract

It has been demonstrated that Na⁺ down-regulates IgE-dependent and IgE-independent histamine release from basophils of normal subjects. The aim of this study was to evaluate whether Na⁺ exerts its inhibitory effect on basophil histamine release in patients with systemic sclerosis (SSc). Peripheral blood leucocytes were stimulated with anti-IgE, n-formyl-methionyl-leucyl-phenylalanine (fMLP) and IL-3 in the presence of high and low Na⁺ concentrations, and histamine release was measured by a fluorometric method. The dose–response curves of histamine release induced by the above stimuli were similar in SSc patients (n = 15) and in normal subjects (n = 39). Na⁺ removal from the extracellular medium and its isosmotic replacement with choline chloride led to a significant increase of anti-IgE-and fMLP-induced histamine release in normal subjects, but not in SSc patients. In the former population, histamine release induced by an optimal dose of anti-IgE (1/5000) was 26.4 ± 3.1% in high Na⁺ and 59.3 ± 3.5% in low Na⁺ (mean ± s.e.m., P< 0.0001), whereas in the latter population mean histamine release was 20.4 ± 5.1% in high Na⁺ and 15.8 ± 2.9% in low Na⁺ (P NS). A similar trend was observed when basophils were stimulated with fMLP. Na⁺ exerted a dose-dependent inhibitory effect on anti-IgE- and fMLP-induced histamine release in normal subjects, but not in SSc patients. IL-3-induced histamine release from basophils of SSc patients was increased in a low-Na⁺ solution, but to a lesser extent when compared with normal controls. Therefore basophils from normal subjects and SSc patients behave in a different way when stimulated in a low-Na⁺ medium. The inhibitory effect of Na⁺ on basophil histamine release is impaired in SSc patients, and this abnormality could contribute to basophil dysfunction.

Full Text

The Full Text of this article is available as a PDF (363.9 KB).